DAY 1 - Friday, Feb. 7, 2014
WELCOME
Glaucoma 360 covers all angles, all segments—all to finding a cure for glaucoma
Ophthalmology Times welcomes attendees and readers to the 3rd Annual Glaucoma 360, a series of three events uniting research, industry, and philanthropy with one mission–to find a cure for glaucoma.
Three separate events set from Thursday, Feb. 6, to Saturday, Feb. 8, at the Palace Hotel, feature the "Glaucoma 360 Annual Gala" held last night; the "New Horizons Forum" today; and the "CME Symposium," which concludes the meeting on Saturday.
The Glaucoma Research Foundation (GRF), a national nonprofit organization dedicated to finding a cure for glaucoma, is presenting Glaucoma 360. Ophthalmology Times is "The Official Partner and Media Sponsor" for the meeting.
» MORE
GLAUCOMA 360 ANNUAL GALA
Venture capitalist receives Catalyst Award
Honored for his dedicated career in advancing innovative concepts to help patients preserve their vision, William J. Link, PhD, a leading venture capitalist and entrepreneur specializing in ophthalmology, received the 2014 Catalyst Award on Thursday night at the Glaucoma Research Foundation (GRF) Glaucoma 360 Annual Gala. » MORE
Catalyst for a Cure team establishes
targets for glaucoma biomarkers
Several years ago, the Glaucoma Research Foundation (GRF) expanded its initiative to advance glaucoma research through a collaborative approach by creating a second Catalyst for a Cure research team.
The new group was charged with finding biomarkers for the earliest pathologic events in glaucoma onset and progression. The four principal scientists in the Catalyst for Cure Biomarker Initiative updated attendees on their progress.
» MORE
2014 Shaffer Grants for Innovative Glaucoma
Research announced during annual gala
Continuing its commitment to explore novel or promising ideas, the Glaucoma Research Foundation (GRF) announced the top selections for the 2014 Shaffer Grants for Innovative Glaucoma Research at last night's Glaucoma 360 Annual Gala. » MORE
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
|